Qiagen NV (QGEN)
39.23
-0.09
(-0.23%)
USD |
NYSE |
Apr 17, 16:00
39.23
0.00 (0.00%)
After-Hours: 20:00
Qiagen Total Liabilities (Quarterly): 2.307B for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.307B |
| September 30, 2023 | 2.213B |
| June 30, 2023 | 2.724B |
| March 31, 2023 | 2.718B |
| December 31, 2022 | 2.821B |
| September 30, 2022 | 3.189B |
| June 30, 2022 | 2.871B |
| March 31, 2022 | 2.944B |
| December 31, 2021 | 3.050B |
| September 30, 2021 | 3.030B |
| June 30, 2021 | 2.930B |
| March 31, 2021 | 2.913B |
| December 31, 2020 | 3.072B |
| September 30, 2020 | 3.060B |
| June 30, 2020 | 2.674B |
| March 31, 2020 | 2.689B |
| December 31, 2019 | 2.699B |
| September 30, 2019 | 2.675B |
| June 30, 2019 | 2.750B |
| March 31, 2019 | 2.814B |
| December 31, 2018 | 3.113B |
| September 30, 2018 | 2.772B |
| June 30, 2018 | 2.785B |
| March 31, 2018 | 2.525B |
| December 31, 2017 | 2.498B |
| Date | Value |
|---|---|
| September 30, 2017 | 2.530B |
| June 30, 2017 | 2.051B |
| March 31, 2017 | 1.638B |
| December 31, 2016 | 1.701B |
| September 30, 2016 | 1.662B |
| June 30, 2016 | 1.492B |
| March 31, 2016 | 1.495B |
| December 31, 2015 | 1.611B |
| September 30, 2015 | 1.639B |
| June 30, 2015 | 1.594B |
| March 31, 2015 | 1.691B |
| December 31, 2014 | 1.796B |
| September 30, 2014 | 1.748B |
| June 30, 2014 | 1.809B |
| March 31, 2014 | 1.754B |
| December 31, 2013 | 1.365B |
| September 30, 2013 | 1.379B |
| June 30, 2013 | 1.381B |
| March 31, 2013 | 1.343B |
| December 31, 2012 | 1.363B |
| September 30, 2012 | 1.245B |
| June 30, 2012 | 1.235B |
| March 31, 2012 | 1.163B |
| December 31, 2011 | 1.172B |
| September 30, 2011 | 1.364B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
2.213B
Minimum
Sep 2023
3.189B
Maximum
Sep 2022
2.807B
Average
2.821B
Median
Dec 2022
Total Liabilities (Quarterly) Benchmarks
| MoonLake Immunotherapeutics | 13.05M |
| LENZ Therapeutics Inc | -- |
| Thermo Fisher Scientific Inc | 51.88B |
| uniQure NV | 624.02M |
| ProQR Therapeutics NV | 106.66M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.115B |
| Shareholders Equity (Quarterly) | 3.808B |
| Debt to Equity Ratio | 0.3965 |
| Current Ratio | 1.990 |
| Net Debt Paydown Yield | 1.57% |